Retrospective Cross-Sectional Epidemiological Study of Human Papillomavirus-Associated Precancers and Anogenital Warts in Patients Attending Specialized Clinics in Russian Federation
- 作者: Briko N.I.1, Lopukhov P.D.1, Zarochentseva N.V.2, Baranov I.I.3, Kachalina O.V.4, Ziganshin O.R.5, Shuldyakov A.A.6
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Moscow Regional Research Institute of Obstetrics and Gynecology
- National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov
- Privolzhsky Research Medical University
- Chelyabinsk Regional Clinical Dermatovenerologic Dispensary
- Saratov State Medical University
- 期: 卷 79, 编号 2 (2024)
- 页面: 158-167
- 栏目: ONCOLOGY: CURRENT ISSUES
- URL: https://ogarev-online.ru/vramn/article/view/257952
- DOI: https://doi.org/10.15690/vramn15266
- ID: 257952
如何引用文章
全文:
详细
Background. In Russia, there are no country level registries on HPV-associated pre-cancers (cervical intraepithelial neoplasia, CIN; vulvar intraepithelial neoplasia, VIN; vaginal intraepithelial neoplasia, VaIN; anal intraepithelial neoplasia, AIN; penile intraepithelial neoplasia PIN) and anogenital warts (AWs) and no national-level cervical cancer screening program.
Aims — the aim of this study was to assess the proportion of patients with CIN, VIN, VaIN, AIN, PIN and AWs diagnosis in the clinical settings in Russia.
Methods. This study was a non-interventional retrospective multi-center chart-review study in 28 investigational sites representing 21 Federal subjects of 6 Federal Districts of Russia. Medical charts of adult men and women visited gynecology, sexual health, dermatovenerology or urology services between 1 Jan 2000 — 31 Dec 2019 were reviewed. Data were abstracted, using a standardized approach, on patient demographic characteristics, presence or absence of pre-cancers and AWs diagnoses, method of diagnosing pre-cancer and HPV infection, and grade of neoplasia.
Results. A total of 11 520 patients (1732 male and 9788 female) were included in the analysis. The overall proportion of patients with HPV-associated precancers and AWs was 10.8%. By service type, cases of HPV-associated conditions were revealed most often in dermatological departments (14.5%) and gynecological hospitals (13.8%). CIN detection rate in Russian clinical settings increased over the 20-years from 3.2 to 11.1% and was higher in gynecological in-patient departments compared to out-patient departments (12.5 and 5.2% respectively). The number of non-cervical precancers (VIN, VaIN, AIN, PIN) cases were very low (the detection rate was less than 1%). The frequency of HPV type 16 and 18 detection increased from 0.6 to 4.8%, and from 0.2 to 1.9%, respectively, for the 20-years period.
Conclusions. Our study suggested high level of HPV-related pre-cancer and AW disease burden as well as presence of high-risk HPV types. Preventive strategy through effective national HPV immunization program would be beneficial to reduce HPV-related disease burden in Russia.
作者简介
Nikolay Briko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: briko_n_i@staff.sechenov.ru
ORCID iD: 0000-0002-6446-2744
SPIN 代码: 2992-6915
MD, PhD, Professor, Academician of the RAS
俄罗斯联邦, MoscowPlaton Lopukhov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: Lopukhov_p_d@staff.sechenov.ru
ORCID iD: 0000-0002-0872-2214
SPIN 代码: 1250-6839
MD, PhD
俄罗斯联邦, MoscowNina Zarochentseva
Moscow Regional Research Institute of Obstetrics and Gynecology
编辑信件的主要联系方式.
Email: ninazar11@mail.ru
ORCID iD: 0000-0001-6155-788X
SPIN 代码: 4737-5826
MD, PhD, Professor
俄罗斯联邦, MoscowIgor Baranov
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov
Email: i_baranov@oparina4.ru
ORCID iD: 0000-0002-9813-2823
SPIN 代码: 4224-0437
MD, PhD, Professor
俄罗斯联邦, MoscowOlga Kachalina
Privolzhsky Research Medical University
Email: yandr24@bk.ru
ORCID iD: 0000-0002-6218-8614
SPIN 代码: 9730-3930
MD, PhD, Professor
俄罗斯联邦, Nizhny NovgorodOleg Ziganshin
Chelyabinsk Regional Clinical Dermatovenerologic Dispensary
Email: ziganshin_oleg@mail.ru
ORCID iD: 0000-0002-5857-0319
SPIN 代码: 5339-2533
MD, PhD, Professor
俄罗斯联邦, ChelyabinskAndrey Shuldyakov
Saratov State Medical University
Email: shuldaykov@mail.ru
ORCID iD: 0000-0002-3009-9262
SPIN 代码: 1157-7585
MD, PhD, Professor
俄罗斯联邦, Saratov参考
- Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778–789. doi: https://doi.org/10.1002/ijc.33588
- Каприн А.Д., Аполихин О.И., Сивков А.В., и др. Междисциплинарный подход к улучшению репродуктивного здоровья подростков и взрослого населения // Эпидемиология и вакцинопрофилактика. — 2022. — Т. 21. — № 1. — С. 103–109. [Kaprin AD, Apolikhin OI, Sivkov AV, et al. Interdisciplinary Approach to Improving the Reproductive Health of Adolescents and Adults. Epidemiology and Vaccinal Prevention. 2022;21(1):103–109. (In Russ.)] doi: https://doi.org/10.31631/2073-3046-2022-21-1-103-109
- Баранов А.А., Намазова-Баранова Л.С., Таточенко В.К., и др. Вакцинопрофилактика заболеваний, вызванных вирусом папилломы человека: позиции доказательной медицины // Обзор клинических рекомендаций. Вопросы современной педиатрии. — 2017. — T. 16. — № 2. — C. 107–117. [Baranov AА, Namazova-Baranova LS, Tatochenko VK, et al. Vaccinal Prevention of the Diseases Caused by Human Papillomavirus: Evidence-Based Medicine. Review of Clinical Guidelines. Current Pediatrics. 2017;16(2):107–117. (In Russ.)] doi: https://doi.org/10.15690/vsp.v1
- de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324(1):17–27. doi: https://doi.org/10.1016/j.virol.2004.03.033
- Bernard HU, Burk RD, Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal oftaxonomic amendments. Virology. 2010;401(1):70–79. doi: https://doi.org/10.1016/j.virol.2010.02.002
- Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncology. 2005;6(4):204. doi: https://doi.org/10.1016/s1470-2045(05)70086-3
- de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–e190. doi: https://doi.org/10.1016/S2214-109X(19)30488-7
- Bräutigam K, Meier S, Meneder S, et al. Distribution of HPV Subtypes in Diverse Anogenital and Oral Samples from Women and Correlation of Infections with Neoplasia of the Cervix. Cancers (Basel). 2022;14(13):3136. doi: https://doi.org/10.3390/cancers14133136
- Fairley CK, Donovan B. What can surveillance of genital warts tell us? Sex Health. 2010;7(3):325–327. doi: https://doi.org/10.1071/SH09145
- Брико Н.И., Лопухов П.Д., Каприн А.Д., и др. ВПЧ-ассоциированные поражения в Российской Федерации: оценка состояния проблемы // Современная онкология. — 2019. — Т. 21. — № 1. — С. 45–50. [Briko NI, Lopukhov PD, Kaprin AD, et al. HPV-associated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019;21(1):45–50. (In Russ.)] doi: https://doi.org/10.26442/18151434.2019.190199
- Каприн А.Д., Новикова Е.Г., Трушина О.И., и др. Скрининг рака шейки матки — нерешенные проблемы // Исследования и практика в медицине. — 2015. — Т. 2. — № 1. — С. 36–41. [Kaprin AD, Novikova EG, Trushina OI, et al. The cervical cancer screening — unsolved problems. Research and Practical Medicine Journal. 2015;2(1):36–41. (In Russ.)] doi: https://doi.org/10.17709/2409-2231-2015-2-1-36-41
- McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425–434. doi: https://doi.org/10.1016/S1470-2045(08)70103-7
- Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023.
- Bosch FX, Robles C, Díaz M, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol. 2016;13(2):119–132. doi: https://doi.org/10.1038/nrclinonc.2015.146
- Кубанов А.А., Богданова Е.В. Динамика заболеваемости инфекциями, передаваемыми половым путем, в различных группах взрослого населения Российской Федерации в 2011–2019 годах // Инфекционные болезни. — 2020. — Т. 18. — № 4. — С. 58–73. [Kubanov AA, Bogdanova EV. Dynamics of the incidence of sexually transmitted infections in different groups of the adult population in the Russian Federation in 2011–2019. Infekc. bolezni (Infectious diseases). 2020;18(4):58–73. (In Russ.)] doi: https://doi.org/10.20953/1729-9225-2020-4-58-73
- Lei J, Ploner A, Miriam Elfström K, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020;383(14):1340–1348. doi: https://doi.org/10.1056/NEJMoa1917338
- Machalek DA, Garland SM, Brotherton JML, et al. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year-Old Australian Women 9 Years Following Implementation of Vaccination. J Infect Dis. 2018;217(10):1590–1600. doi: https://doi.org/10.1093/infdis/jiy075
补充文件
